BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$84M 1.2%
3,746,086
+196,000
27
$83.6M 1.2%
755,898
-383,557
28
$82.7M 1.19%
2,629,172
-258,087
29
$79.4M 1.14%
240,590
-7,723
30
$76.8M 1.1%
276,132
-94,567
31
$74.9M 1.08%
1,566,015
+250,142
32
$74.6M 1.07%
334,838
-8,144
33
$71.3M 1.02%
401,768
-5,289
34
$69.3M 0.99%
860,460
-68,048
35
$69.2M 0.99%
3,214,704
-406,858
36
$68.8M 0.99%
1,007,444
-198,978
37
$67.2M 0.96%
1,869,055
-149,466
38
$65.1M 0.93%
134,206
-11,103
39
$60.7M 0.87%
928,305
+6,300
40
$58M 0.83%
598,934
+13,780
41
$52.5M 0.75%
285,789
-6,982
42
$52.4M 0.75%
188,701
-4,956
43
$51.8M 0.74%
262,993
+31,924
44
$50.6M 0.73%
1,800,000
+875,000
45
$49.7M 0.71%
615,926
-29,580
46
$47.1M 0.68%
1,047,356
+70
47
$44.3M 0.64%
2,601,446
+63,922
48
$42.5M 0.61%
101,818
+10,657
49
$41.9M 0.6%
2,673,500
-5,000
50
$41.1M 0.59%
528,440
-17,463
1
2
3 4 5